Active Ingredient: ASCIMINIB HYDROCHLORIDE
Proprietary Name: SCEMBLIX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215358
Product Number: 002
Approval Date: Oct 29, 2021
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
